Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS) (CSID GPS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01914003|
Recruitment Status : Completed
First Posted : August 1, 2013
Results First Posted : October 10, 2016
Last Update Posted : November 6, 2017
|Condition or disease|
|Congenital Sucrase-isomaltase Deficiency (CSID)|
|Study Type :||Observational|
|Actual Enrollment :||53 participants|
|Official Title:||A Multi-Center Study of the Prevalence of Known Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Variants and Functional Sucrase Activity by 13C-Sucrose Breath Test in Children With Chronic Diarrhea or Chronic Abdominal Pain|
|Study Start Date :||May 2013|
|Actual Primary Completion Date :||May 2015|
|Actual Study Completion Date :||July 2015|
Individual has one or more known CSID mutations.
Individual does not have any known CSID mutations.
- Prevalence of CSID Genetic Variants [ Time Frame: 1 year ]Prevalence of CSID genetic variants in subjects 18 years of age or younger with a primary symptom of chronic idiopathic diarrhea or chronic abdominal pain without constipation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01914003